-0.43 | -1.73%
| Price and Volume | |
|---|---|
| Recent Price | 24.89 |
| 52 Week High | 26.75 |
| 52 Week Low | 6.13 |
| Avg. Daily Vol. (Mil) | 5.22 |
| Beta (3 year) | 1.53 |
| Share Related Items | |
| Mkt Cap (Mil) | 2,481.56 |
| Shares Out (Mil) | 99.70 |
| Float (Mil) | 99.35 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 25.00 |
| Current Ratio | 25.90 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.00 |
| Price/Book | 7.62 |
| Price/Cash Flow | -45.10 |
| Per Share Data | |
| Earnings | -0.63 |
| Sales | 0.00 |
| Book Value | 3.27 |
| Cash Flow | -0.55 |
| Business Summary | |
|---|---|
| VIVUS, Inc. is engaged in the development and commercialization of therapeutic products for large underserved markets. | |
| General Information | |
| 1172 Castro Street
Mountain View, CA 94040 |
|
| www.vivus.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 38 | |
| CEO: Leland F. Wilson | |
| Short Interest | |
| Current Month (Mil) | 15.16 |
| Previous Month (Mil) | 13.74 |
| Short Interest Ratio (Days) | 3.90 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -16.30 |
| Return on Investments | -16.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,419.86 | 1,313.32 | 2,837.36 | 16.25 |
Oil *
103.00
|
|
DOWN
160.83 |
DOWN
19.10 |
DOWN
33.63 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
151.91
|
|
-1.28%
|
-1.43%
|
-1.17%
|
-6.12%
|
Data delayed 20 minutes |
Connect with TheStreet